Tezepelumab
Tezepelumab is a pharmaceutical drug with 37 clinical trials. Currently 13 active trials ongoing. Historical success rate of 87.5%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
8
Mid Stage
19
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
14 of 16 finished
12.5%
2 ended early
13
trials recruiting
37
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
Clinical Trials (37)
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy
A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
Tezspire Cardiac Events PASS
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres
Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)
Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma
Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States
Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps
Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 37